References
- Marshall BDL, Krieger MS, Yedinak JL, Ogera P, Banerjee P, Alexander-Scott NE, Rich JD, Green TC. Epidemiology of fentanyl-involved drug overdose deaths: A geospatial retrospective study in Rhode Island, USA. Int J Drug Policy. 2017;46:130–35. doi:https://doi.org/10.1016/j.drugpo.2017.05.029.
- Xibiao Y, Jenny S, Bonnie H, Mark T, Kendall P. At-a-glance - impact of drug overdose-related deaths on life expectancy at birth in British Columbia. Health Promot Chronic Dis Prev Can. 2018;38:248–51. doi:https://doi.org/10.24095/hpcdp.38.6.05.
- British Columbia Corner’s Service. Fentanyl-detected illicit drug overdose deaths january 1, 2012 to june 30,2019. https://www2.gov.bc.ca/assets/gov/birthadoption-death-marriage-and divorce/deaths/coroners-service/statistical/fentanyl-detected-overdose.pdf.Published. Accessed August 17, 2019
- Dowell D, Noonan RK, Houry D. Underlying factors in drug overdose deaths. JAMA. 2017;318:2295–96. doi:https://doi.org/10.1001/jama.2017.15971.
- Vancouver Coastal Health. Drug checking at Insite shows potential for preventing fentanyl-related overdoses - Vancouver coastal health. http://www.vch.ca/about-us/news/news-releases/drug-checking-at-insite-shows-potential-for-preventing-fentanyl-related-overdoses. PublishedMay15,2017 Accessed May 16, 2018.
- Tupper KW, McCrae K, Garber I, Lysyshyn M, Wood E. Initial results of a drug checking pilot program to detect fentanyl adulteration in a canadian setting. Drug Alcohol Depend. 2018;190:242–45. doi:https://doi.org/10.1016/j.drugalcdep.2018.06.020.
- Moallef S, Nosova E, Milloy MJ, DeBeck K, Fairbairn N, Wood E, Kerr T, Hayashi K. Knowledge of fentanyl and perceived risk of overdose among persons who use drugs in Vancouver, Canada. Public Health Rep. 2019;134:423–31. doi:https://doi.org/10.1177/0033354919857084.
- Carroll JJ, Marshall BDL, Rich JD, Green TC. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study. Int J Drug Policy. 2017;46:136–45. doi:https://doi.org/10.1016/j.drugpo.2017.05.023.
- McKnight C, Des Jarlais DC. Being “hooked up” during a sharp increase in the availability of illicitly manufactured fentanyl: adaptations of drug using practices among people who use drugs (PWUD) in New York City. Int J Drug Policy. 2018;60:82–88. doi:https://doi.org/10.1016/j.drugpo.2018.08.004.
- Macmadu A, Carroll JJ, Hadland SE, Green TC, Marshall BD. Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically. Addict Behav. 2017;68:35–38. doi:https://doi.org/10.1016/j.addbeh.2017.01.014.
- Amlani A, McKee G, Khamis N, Raghukumar G, Tsang E, Buxton JA. Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada. Harm Reduct J. 2015;12:54. doi:https://doi.org/10.1186/s12954-015-0088-4.
- Rouhani S, Park JN, Morales KB, Green TC, Sherman SG. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence. Harm Reduct J. 2019;16:39. doi:https://doi.org/10.1186/s12954-019-0311-9.
- Walton G, Dong H, Milloy MJ, DeBeck K, Kerr T, Wood E, Hayashi K. Increasing availability of benzodiazepines among people who inject drugs in a Canadian setting. Subst Abus. 2018;39(1):69–76.
- Silverstein JH, Rieders MF, McMullin M, Schulman S, Zahl K. An analysis of the duration of fentanyl and its metabolites in urine and saliva. Anesth Analg. 1993;76:618–21. doi:https://doi.org/10.1213/00000539-199303000-00030.
- Mars SG, Ondocsin J, Ciccarone D. Sold as heroin: perceptions and use of an evolving drug in Baltimore, MD. J Psychoactive Drugs. 2018;50:167–76. doi:https://doi.org/10.1080/02791072.2017.1394508.
- Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy. 2009;20:193–201. doi:https://doi.org/10.1016/j.drugpo.2008.10.003.
- Tim R. The ‘risk environment’: a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13(2):85–94.
- Hayashi K, Milloy MJ, Lysyshyn M, DeBeck K, Nosova E, Wood E, Kerr T. Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study. Drug Alcohol Depend. 2018;183:1–6. doi:https://doi.org/10.1016/j.drugalcdep.2017.10.020.
- Burnham KAD. Model selection and multimodal inference. second ed. New York, N.Y: Springer-Verlag; 2002.
- Bardwell G, Boyd J, Arredondo J, McNeil R, Kerr T. Trusting the source: the potential role of drug dealers in reducing drug-related harms via drug checking. Drug Alcohol Depend. 2019;198:1–6. doi:https://doi.org/10.1016/j.drugalcdep.2019.01.035.
- Karamouzian M, Dohoo C, Forsting S, McNeil R, Kerr T, Lysyshyn M. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada. Harm Reduct J. 2018;15:46. doi:https://doi.org/10.1186/s12954-018-0252-8.
- O’Donnell J, Gladden R, Mattson C, Kariisa M. Notes from the field: overdose deaths with carfentanil and other fentanyl analogs detected — 10 states, july 2016–june 2017. MMWR; 2018;67(27):767–68. doi:https://doi.org/10.15585/mmwr.mm6727a4.
- British Columbia Coroner Service. Illicit drug toxicity deaths in bc january 1, 2009 to october 31, 2019 2019. https://www2.gov.bc.ca/assets/gov/birth-adoption-death-marriage-and-divorce/deaths/coroners-service/statistical/illicit-drug.pdf. Published December5,2019 . Accessed January 26, 2020.
- Stover HJ, Schaffer D. SMOKE IT! promoting a change of opiate consumption pattern - from injecting to inhaling. Harm Reduct J. 2014;11:18. doi:https://doi.org/10.1186/1477-7517-11-18.
- George AV, Lu JJ, Pisano MV, Metz J, Erickson TB. Carfentanil–an ultra potent opioid. Am J Emerg Med. 2010;28:530–32. doi:https://doi.org/10.1016/j.ajem.2010.03.003.
- Bardwell G, Fleming T, Collins AB, Boyd J, McNeil R. Addressing intersecting housing and overdose crises in Vancouver, Canada: opportunities and challenges from a tenant-led overdose response intervention in single room occupancy hotels. J Urban Health. 2019;96(1):12–20.
- Boyd J, Collins AB, Mayer S, Maher L, Kerr T, McNeil R. Gendered violence and overdose prevention sites: a rapid ethnographic study during an overdose epidemic in Vancouver, Canada. Addiction. 2018;113:2261–70. doi:https://doi.org/10.1111/add.14417.
- Gowing L, Farrell M, Bornemann R, Sullivan L, Ali R. Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2008;Cd004145.
- MacArthur GJ, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J, Degenhardt L, Hickman M. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ. 2012;345:e5945. doi:https://doi.org/10.1136/bmj.e5945.
- van Ameijden EJ, Langendam MW, Coutinho RA. Dose-effect relationship between overdose mortality and prescribed methadone dosage in low-threshold maintenance programs. Addict Behav. 1999;24:559–63. doi:https://doi.org/10.1016/S0306-4603(98)00083-5.
- Rowe C, Santos GM, Behar E, Coffin PO. Correlates of overdose risk perception among illicit opioid users. Drug Alcohol Depend. 2016;159:234–39. doi:https://doi.org/10.1016/j.drugalcdep.2015.12.018.
- McGregor C, Darke S, Ali R, Christie P. Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. Addiction. 1998;93:701–11. doi:https://doi.org/10.1046/j.1360-0443.1998.9357016.x.
- Rawson RA, McCann MJ, Flammino F, Shoptaw S, Miotto K, Reiber C, Ling W. A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals. Addiction. 2006;101:267–74.
- Karila L, Reynaud M, Aubin HJ, Rolland B, Guardia D, Cottencin O, Benyamina A. Pharmacological treatments for cocaine dependence: is there something new? Curr Pharm Des. 2011;17:1359–68.